Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Shah Nimish P
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   0    

Indirect Shares

   50,221,732      
Direct Value   $0    

Indirect Value

   $415,597,346      
Total Shares   50,221,732      
Total Value   $415,597,346      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    66   
    4    

     Stock price went up :
    4   
    0    
     Stock price went down :
    62   
    4    
   
     Gain/Loss Ratio :
   0.0   
   -4.0   
     Percentage Gain/Loss :
   -54.4%
 -384.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bellerophon Therapeutics Inc BLPH 10% Owner 2018-08-14 0 2018-09-17 7,386,163    Premium*  
            Kalvista Pharmaceuticals Inc KALV 10% Owner 2019-03-18 0 2024-02-08 4,824,731    Premium*  
            Constellation Pharmaceuticals Inc CNST 10% Owner 0 2019-12-13 4,016,873    Premium*  
            Altimmune, Inc ALT 10% Owner 2020-05-26 0 2021-02-25 3,500,000    Premium*  
            Cogent Biosciences, Inc. COGT 10% Owner 2020-08-14 0 2020-08-18 4,355,273    Premium*  
            Tricida, Inc. TCDA 10% Owner 2022-06-02 0 2022-10-26 3,751,406    Premium*  
            Vistagen Therapeutics Inc VTGN 10% Owner 0 2022-07-12 20,637,286    Premium*  
            Apogee Therapeutics, Inc. APGE Director 2023-07-13 0 2023-07-13 1,750,000    Premium*  
* Premium Members only  

Records found :    93         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-23 4 B $12.54 $136,648 I/I 10,897 4,538,094 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-22 4 B $12.55 $847,702 I/I 67,546 4,527,197 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-09 4 B $12.56 $261,449 I/I 20,816 4,242,100 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-17 4 B $12.60 $994,455 I/I 78,925 4,394,971 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-10 4 B $12.67 $604,359 I/I 47,700 4,289,800 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-11 4 B $12.68 $84,284 I/I 6,647 4,296,447 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-16 4 B $12.73 $249,495 I/I 19,599 4,316,046 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-25 4 B $12.73 $89,492 I/I 7,030 4,565,810 1.5 %
TCDA Tricida, Inc. 10% Owner   –       –       •   2022-09-02 4 B $12.76 $804,263 I/I 63,030 7,670,981 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-26 4 B $12.98 $54,179 I/I 4,174 4,569,984 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-29 4 B $14.22 $1,146,132 I/I 80,600 4,650,584 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-01-30 4 B $14.47 $1,274,793 I/I 88,099 4,738,683 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-02-07 4 B $14.56 $754,601 I/I 51,827 4,794,984 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-02-08 4 B $14.70 $437,281 I/I 29,747 4,824,731 1.5 %
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2024-02-06 4 B $14.74 $65,947 I/I 4,474 4,743,157 1.5 %
APGE Apogee Therapeutics, Inc. Director   –       •      –    2023-07-13 4 B $17.00 $29,750,000 I/I 1,750,000 1,750,000 2.1 -
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2019-03-18 4 S $28.75 $14,375,000 I/I (500,000) 1,544,112 0 -
CNST Constellation Pharmaceuti... 10% Owner   –       –       •   2019-12-13 4 B $34.50 $13,800,000 I/I 400,000 4,016,873 1.5 -
  93  Records found
  1   2   3   4     
  Page 4 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us